Premier Fund Managers Ltd Buys 11,009 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Premier Fund Managers Ltd raised its stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 67.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 27,243 shares of the company's stock after acquiring an additional 11,009 shares during the quarter. Premier Fund Managers Ltd's holdings in Astrana Health were worth $871,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of ASTH. Quarry LP bought a new position in Astrana Health during the third quarter valued at $77,000. KBC Group NV increased its holdings in Astrana Health by 108.4% in the 4th quarter. KBC Group NV now owns 2,530 shares of the company's stock worth $80,000 after acquiring an additional 1,316 shares during the last quarter. Quest Partners LLC purchased a new stake in Astrana Health in the 3rd quarter worth about $133,000. US Bancorp DE lifted its holdings in Astrana Health by 3,880.0% during the fourth quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after purchasing an additional 4,656 shares during the last quarter. Finally, Paloma Partners Management Co bought a new position in Astrana Health during the third quarter worth about $220,000. 52.77% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Bank of America dropped their price target on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a research note on Tuesday, March 4th. Macquarie raised Astrana Health to a "hold" rating in a report on Monday, December 16th. Robert W. Baird decreased their price objective on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Truist Financial cut their target price on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Finally, Barclays initiated coverage on Astrana Health in a research report on Tuesday. They set an "equal weight" rating and a $36.00 price target on the stock. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $53.29.

Astrana Health Price Performance

ASTH traded down $0.65 on Tuesday, reaching $30.37. The company had a trading volume of 59,630 shares, compared to its average volume of 262,052. The business has a 50 day simple moving average of $33.77 and a 200 day simple moving average of $41.75. The company has a market cap of $1.52 billion, a price-to-earnings ratio of 23.37, a P/E/G ratio of 1.37 and a beta of 1.30. Astrana Health, Inc. has a 52-week low of $23.12 and a 52-week high of $63.20. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.37). The firm had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. As a group, sell-side analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.